Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Piraccini

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Drug Safety|April 1, 1994
Drug-induced hair loss and hair growth. Incidence, management and avoidanceA Tosi, C Misciali, B M Piraccini, et al.
Dermatology (Basel, Switzerland)|January 1, 1992
Atrichia and papular lesions: report of a caseC Misciali, A Tosti, P A Fanti, et al.
Clinical and Experimental Dermatology|December 18, 2014
A longitudinal pigmented band on the right index fingernailP A Fanti, E Dika, A Ismaili, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Nail matrix nevi: a clinical and histopathologic study of twenty-two patientsA Tosti, R Baran, B M Piraccini, et al.
Acta Dermato-Venereologica|September 1, 1995
Epidermolytic hyperkeratosis of the nails in keratosis palmoplantaris nummularisA Tosti, P A Fanti, B M Piraccini, et al.
Journal of the American Academy of Dermatology|August 1, 1994
Characterization of nail matrix melanocytes with anti-PEP1, anti-PEP8, TMH-1, and HMB-45 antibodiesA Tosti, N Cameli, B M Piraccini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2020
The red half-moon nail sign: a novel manifestation of coronavirus infectionI Neri, A Guglielmo, A Virdi, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Idiopathic atrophy of the nails: clinical and pathological study of 2 casesA Tosti, B M Piraccini, P A Fanti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2015
Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patientsB M Piraccini, A Alessandrini, E Dika, et al.
Annales De Dermatologie Et De Venereologie|October 9, 2023
Self-induced nail disorders (SINDs): What do we know so far?M Starace, S Cedirian, A Alessandrini, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Drug Safety|April 1, 1994
Drug-induced hair loss and hair growth. Incidence, management and avoidanceA Tosi, C Misciali, B M Piraccini, et al.
Dermatology (Basel, Switzerland)|January 1, 1992
Atrichia and papular lesions: report of a caseC Misciali, A Tosti, P A Fanti, et al.
Clinical and Experimental Dermatology|December 18, 2014
A longitudinal pigmented band on the right index fingernailP A Fanti, E Dika, A Ismaili, et al.
Journal of the American Academy of Dermatology|May 1, 1996
Nail matrix nevi: a clinical and histopathologic study of twenty-two patientsA Tosti, R Baran, B M Piraccini, et al.
Acta Dermato-Venereologica|September 1, 1995
Epidermolytic hyperkeratosis of the nails in keratosis palmoplantaris nummularisA Tosti, P A Fanti, B M Piraccini, et al.
Journal of the American Academy of Dermatology|August 1, 1994
Characterization of nail matrix melanocytes with anti-PEP1, anti-PEP8, TMH-1, and HMB-45 antibodiesA Tosti, N Cameli, B M Piraccini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2020
The red half-moon nail sign: a novel manifestation of coronavirus infectionI Neri, A Guglielmo, A Virdi, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
Idiopathic atrophy of the nails: clinical and pathological study of 2 casesA Tosti, B M Piraccini, P A Fanti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2015
Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patientsB M Piraccini, A Alessandrini, E Dika, et al.
Annales De Dermatologie Et De Venereologie|October 9, 2023
Self-induced nail disorders (SINDs): What do we know so far?M Starace, S Cedirian, A Alessandrini, et al.
Pageof 14